# Hierarchical micro-/nanostructured hydroxyapatite scaffolds promote osteoporotic bone regeneration via activation of hedgehog and HIF-1α signaling

**Authors:** Rui Zhao, Jiayi Chen, Yongjia Li, Hui Qian, Xiangdong Zhu, Grazia Raucci Maria, Luigi Ambrosio, Xiao Yang, Xingdong Zhang

PMC · DOI: 10.1016/j.bioactmat.2026.01.049 · Bioactive Materials · 2026-02-05

## TL;DR

A new type of bone scaffold improves bone regeneration in osteoporosis by activating key signaling pathways and promoting blood vessel growth.

## Contribution

Hierarchical micro-/nanostructured hydroxyapatite scaffolds are introduced as a programmable platform for osteoporotic bone repair.

## Key findings

- Nanofiber-coated scaffolds enhance bone volume and mechanical strength in osteoporotic models.
- Three ossification patterns are induced based on scaffold morphology and local environment.
- Hedgehog and HIF-1α signaling pathways are activated to promote coordinated osteogenesis and angiogenesis.

## Abstract

Osteoporotic bone defects remain a major clinical challenge due to impaired osteogenesis, disrupted angiogenesis, and poor scaffold integration. To overcome these limitations, we developed hierarchical micro-/nanostructured hydroxyapatite (nwHA) scaffolds by integrating morphology-specific nanohydroxyapatite (nHA) onto whisker-reinforced hydroxyapatite (wHA) scaffolds. This modular strategy decouples mechanical strength from interfacial bioactivity, enabling programmable topographical control. Five distinct nHA morphologies were used to functionalize wHA scaffolds, which were systematically evaluated both in vitro and in osteoporotic rat models. Among them, nanofiber-coated scaffolds (nwHA1) significantly enhanced bone volume fraction, mineral apposition rate, mechanical strength, and neovascularization. Histological analysis identified three distinct ossification patterns—type I (wall-penetrating), type II (surface-appositional), and a hybrid endochondral–intramembranous mode—whose distribution varied with nHA morphology and the local microenvironment. Mechanistically, nwHA1 activated canonical Hedgehog signaling and upregulated HIF-1α in both MSCs and HUVECs, thereby promoting coordinated osteogenic and angiogenic responses. Pharmacological inhibition with cyclopamine, as well as siRNA-mediated knockdown of GLI1 or HIF-1α, significantly attenuated these pro-osteoangiogenic markers, confirming functional crosstalk between Hedgehog and hypoxia signaling pathways in response to scaffold-induced topographic cues. These findings establish nHA morphology as a critical topographical regulator of bone regeneration and provide a versatile platform for designing adaptive bioceramics tailored to osteoporotic bone repair.

Image 1

•Morphology-specific nHA-functionalized wHA scaffolds enhance osteogenesis and angiogenesis in osteoporotic bone defects.•Nanofiber-coated nwHA1 scaffolds enhance bone regeneration and angiogenesis via Hedgehog-mediated osteoinduction.•Three ossification modes (Type I, Type II, hybrid) are induced, guided by nHA topography and defect microenvironment.•Hedgehog pathway activation upregulates SHH and GLI1, driving MSC differentiation and matrix mineralization.•Nanoscale topography offers a programmable platform for adaptive bioceramics in osteoporotic bone repair.

Morphology-specific nHA-functionalized wHA scaffolds enhance osteogenesis and angiogenesis in osteoporotic bone defects.

Nanofiber-coated nwHA1 scaffolds enhance bone regeneration and angiogenesis via Hedgehog-mediated osteoinduction.

Three ossification modes (Type I, Type II, hybrid) are induced, guided by nHA topography and defect microenvironment.

Hedgehog pathway activation upregulates SHH and GLI1, driving MSC differentiation and matrix mineralization.

Nanoscale topography offers a programmable platform for adaptive bioceramics in osteoporotic bone repair.

## Linked entities

- **Genes:** SHH (sonic hedgehog signaling molecule) [NCBI Gene 6469], GLI1 (GLI family zinc finger 1) [NCBI Gene 2735], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091]
- **Chemicals:** cyclopamine (PubChem CID 442972)
- **Diseases:** osteoporosis (MONDO:0005298)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, Gli1 (GLI family zinc finger 1) [NCBI Gene 140589] {aka Gli}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Blnk (B cell linker) [NCBI Gene 17060] {aka BASH, Bca, Ly-57, Ly57, Lyw-57, SLP-65}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, Actb (actin, beta) [NCBI Gene 81822] {aka Actx}, Alb (albumin) [NCBI Gene 24186] {aka Alb1, Albza}, Pecam1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 29583] {aka CD31, Pecam}, Fgf23 (fibroblast growth factor 23) [NCBI Gene 170583] {aka Fgf8b}, Jak2 (Janus kinase 2) [NCBI Gene 24514], Smo (smoothened, frizzled class receptor) [NCBI Gene 25273] {aka Smoh}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 29373], Gli1 (GLI-Kruppel family member GLI1) [NCBI Gene 14632] {aka Zfp-5, Zfp5}, GLI1 (GLI family zinc finger 1) [NCBI Gene 2735] {aka GLI, PAPA8, PPD1}, PTCH1 (patched 1) [NCBI Gene 5727] {aka BCNS, BCNS1, NBCCS, PTC, PTC1, PTCH}, Ptk2 (protein tyrosine kinase 2) [NCBI Gene 25614] {aka FAK, FRNK, p125FAK}, Hif1a (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 29560] {aka HIF1-alpha, MOP1}, Shh (sonic hedgehog signaling molecule) [NCBI Gene 29499] {aka ShhNC}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, Runx2 (RUNX family transcription factor 2) [NCBI Gene 367218] {aka CBF-alpha-1, Cbfa1, OSF-2}, Gli2 (GLI family zinc finger 2) [NCBI Gene 304729], Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, SHH (sonic hedgehog signaling molecule) [NCBI Gene 6469] {aka HHG1, HLP3, HPE3, MCOPCB5, SMMCI, ShhNC}, alp (alopecia, recessive) [NCBI Gene 11691], Ptch1 (patched 1) [NCBI Gene 19206] {aka A230106A15Rik, Ptc, Ptc1, Ptch, mes, wig}, Ptch1 (patched 1) [NCBI Gene 89830] {aka Ptch, Ptch2}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, Emcn (endomucin) [NCBI Gene 295490], Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 12156] {aka Bmp2a}, VWF (von Willebrand factor) [NCBI Gene 7450] {aka F8VWF, VWD}
- **Diseases:** cytotoxicity (MESH:D064420), bone (MESH:D001847), osteoporotic (MESH:D058866), Osteoporosis (MESH:D010024), infection (MESH:D007239), fracture (MESH:D050723), inflammation (MESH:D007249), degenerative disease (MESH:D019636), femoral defect (MESH:D005266), hypoxia (MESH:D000860), skeletal fragility (MESH:D005600), nonunion (MESH:C538144), estrogen (MESH:D056828)
- **Chemicals:** HA (MESH:D017886), Triton X-100 (MESH:D017830), Fast Green (MESH:C035906), pentobarbital sodium (MESH:D010424), streptomycin (MESH:D013307), C (MESH:D002244), Lipofectamine 2000 (MESH:C086724), FITC (MESH:D016650), xylene (MESH:D014992), Ca(OH)2 (MESH:D002126), nitrogen (MESH:D009584), EDTA (MESH:D004492), phosphate (MESH:D010710), PI (MESH:D010716), P (MESH:D010758), sodium citrate (MESH:D000077559), Phalloidin (MESH:D010590), Hematoxylin (MESH:D006416), sodium dihydrogen phosphate (MESH:C018279), FDA (MESH:C018506), steel (MESH:D013232), ammonia (MESH:D000641), O (MESH:D010100), tetracycline (MESH:D013752), penicillin (MESH:D010406), paraffin (MESH:D010232), H2O2 (MESH:D006861), propidium iodide (MESH:D011419), Calcein-AM (MESH:C085925), Ca(NO3)2 4H2O (-), H&amp;E (MESH:D006371), gold (MESH:D006046), Safranin O (MESH:C009195), Ca(NO3)2 (MESH:C059948), carbonate (MESH:D002254), Toluidine Blue (MESH:D014048), DAPI (MESH:C007293), nitric acid (MESH:D017942), ethanol (MESH:D000431), formalin (MESH:D005557), Ca (MESH:D002118), ARS (MESH:C004468), P5+ (MESH:C016883), Tween-20 (MESH:D011136), CaCl2 (MESH:D002122), alpha-MEM (MESH:C420642), calcium phosphate (MESH:C020243), PBS (MESH:D007854), eosin (MESH:D004801), silicone (MESH:D012828), KBr (MESH:C039004), ammonium hydrogen phosphate (MESH:C024788), sodium hexametaphosphate (MESH:C009285), DAB (MESH:C000469), hydrochloric acid (MESH:D006851), cyclopamine (MESH:C000541), SDS (MESH:D012967), Cu (MESH:D003300), gentamicin (MESH:D005839), PVDF (MESH:C024865)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12919287/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12919287/full.md

## References

63 references — full list in the complete paper: https://tomesphere.com/paper/PMC12919287/full.md

---
Source: https://tomesphere.com/paper/PMC12919287